+Compare
MTEM
Stock ticker:
NASDAQ
AS OF
Jun 27 closing price
Price
$0.99
Change
-$0.07 (-6.60%)
Capitalization
55.61M

MTEM Molecular Templates Forecast, Technical & Fundamental Analysis

a developer of immunotoxins
Industry Biotechnology
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Jun 27, 2022

MTEM sees its Stochastic Oscillator ascends from oversold territory

On June 23, 2022, the Stochastic Oscillator for MTEM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 59 instances where the indicator left the oversold zone. In 51 of the 59 cases the stock moved higher in the following days. This puts the odds of a move higher at over 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MTEM's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 27, 2022. You may want to consider a long position or call options on MTEM as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MTEM just turned positive on May 23, 2022. Looking at past instances where MTEM's MACD turned positive, the stock continued to rise in of 56 cases over the following month. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where MTEM advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for MTEM entered a downward trend on June 23, 2022. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.171) is normal, around the industry mean (24.920). P/E Ratio (0.000) is within average values for comparable stocks, (95.623). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.923). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1.262) is also within normal values, averaging (296.200).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MTEM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTEM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

AI

View a ticker or compare two or three

AI
A.I. Advisor
published Earnings

MTEM is expected to report earnings to rise 31.03% to -49 cents per share on August 11

Molecular Templates MTEM Stock Earnings Reports
Q2'22
Est.
$-0.50
Q1'22
Beat
by $0.09
Q4'21
Beat
by $0.22
Q3'21
Missed
by $0.09
Q2'21
Beat
by $0.02
The last earnings report on May 12 showed earnings per share of -37 cents, beating the estimate of -47 cents. With 363.20K shares outstanding, the current market capitalization sits at 55.61M.
AI
A.I. Advisor
published General Information

General Information

a developer of immunotoxins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9301 Amberglen Boulevard
Phone
+1 512 869-1555
Employees
261
Web
https://www.mtem.com

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EQ1.740.04
+2.35%
Equillium
STAR14.05N/A
N/A
ISTAR
SIRE16.97-0.08
-0.47%
Sisecam Resources LP
AB42.75-0.40
-0.93%
AllianceBernstein Holding LP
SHW227.15-4.11
-1.78%
Sherwin-Williams Company (The)

MTEM and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTEM has been loosely correlated with IBRX. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if MTEM jumps, then IBRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTEM
1D Price
Change %
MTEM100%
-6.89%
IBRX - MTEM
55%
Loosely correlated
-6.01%
INO - MTEM
55%
Loosely correlated
+0.52%
VIRX - MTEM
55%
Loosely correlated
+9.80%
AGIO - MTEM
55%
Loosely correlated
+2.57%
FBIO - MTEM
54%
Loosely correlated
-2.76%
More